ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: TH-PO680

Inhibition of Wnt/β-Catenin Signaling Slowed Cystogenesis in Postnatal Mouse Model of ADPKD

Session Information

Category: Genetic Diseases of the Kidney

  • 1001 Genetic Diseases of the Kidney: Cystic

Authors

  • Jung, Yun Joon, Boston Children's Hospital, Boston, Massachusetts, United States
  • Kreidberg, Jordan A., Boston Children's Hospital, Boston, Massachusetts, United States
Background

The Wnt signaling pathway has an important role for nephron development and elevated expression of β-catenin, master regulator of the Wnt signaling pathway, is shown to correlate with cystogenesis in autosomal dominant polycystic kidney disease (ADPKD). Here we provide further evidence that inhibition of Wnt/β-catenin pathway slowed cystogenesis in a postnatal model of ADPKD using Ksp-CreERT2;Pkd1flox/flox mice.

Methods

To understand the pathological contribution of Wnt signaling in ADPKD, we measured expression of Wnt gene and β-catenin expression in vivo using two murine models of ADPKD where postnatal cystogenesis could be observed. We also tested the effect on cyst formation of small molecule inhibitors of β-catenin interaction with either CBP or p300.

Results

We observed increased expression of Wnt genes in and higher levels of β-catenin in cystic kidneys of both Hoxb7-Cre-IRES-eGFP;Pkd1flox/flox mice and Ksp-CreERT2;Pkd1flox/flox mice. Although the overall pattern differed between these models, Wnt7a was consistently over-expressed in both models of ADPKD. To test whether canonical Wnt signaling was required for cystogensis, we inactivated one copy of the Ctnnb1 gene, encoding β-catenin, in Ksp-CreERT2;Pkd1flox/flox mice. Reduced progression of cyst enlargement was observed in Ksp-CreERT2;Pkd1flox/flox;Ctnnb1flox/+ mice. Furthermore, treatment of Ksp-CreERT2;Pkd1flox/flox mice with a small molecule, ICG-001, that blocks the interaction of β-catenin with CBP slowed the progression of cyst formation and mice showed reduced kidney:weight to body weight ratio. In contrast, a small molecule, IQ-1, which blocked the interaction of β-catenin with p300 had no effect in cyst progression.

Conclusion

Our study demonstrates that the canonical Wnt signaling pathway has an important role in cystogenesis and inhibition of the β-catenin-CBP complex by ICG-001 may serve as a new therapeutic target to decrease cyst formation.

Funding

  • NIDDK Support